71 – 80 of 272
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Type 2 inflammatory biomarker response after exercise challenge testing
- Contribution to journal › Article
-
Mark
Fractional exhaled breath temperature in patients with asthma, chronic obstructive pulmonary disease, or systemic sclerosis compared to healthy controls
- Contribution to journal › Article
-
Mark
Letter to the editor : Indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: A randomized controlled cross-over study
- Contribution to journal › Article
-
Mark
Allergic Disease among Adolescents, IgE-sensitisation, Health-Related Quality of Life and physical activity
(2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Allergic respiratory disease care in the COVID-19 era : A EUFOREA statement
- Contribution to journal › Letter
-
Mark
A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy
- Contribution to journal › Article
-
Mark
The risk of osteoporosis in patients with asthma
- Contribution to journal › Scientific review
- 2019
-
Mark
IgE sensitization in a cohort of adolescents in southern Sweden and its relation to allergic symptoms
- Contribution to journal › Article
-
Mark
The REal Life EVidence AssessmeNt Tool (RELEVANT) : Development of a novel quality assurance asset to rate observational comparative effectiveness research studies
- Contribution to journal › Article
-
Mark
Quality standards in respiratory real-life effectiveness research : The REal Life EVidence AssessmeNt Tool (RELEVANT): Report from the Respiratory Effectiveness Group - European Academy of Allergy and Clinical Immunology Task Force
- Contribution to journal › Article
